Sign in

CIK 0001842952

  • Emerging growth company

Context Therapeutics Inc.

Sign in to watch
Ticker
CNTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
863738787
Phone
+1 267-225-7416
Business address
2001 MARKET STREET, SUITE 3915 UNIT #15, PHILADELPHIA, PA, 19103
Former names
Context Therapeutics LLC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market buy Chief Executive Officer bought 5,823 shares at $0.84 ($4,900)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market buy Chief Executive Officer bought 5,606 shares at $0.87 ($4,901)
  10. 4 Open-market buy Chief Executive Officer bought 5,040 shares at $0.97 ($4,900)
  11. 4 Open-market buy Chief Executive Officer bought 7,027 shares at $0.70 ($4,901)
  12. 4 Open-market buy Chief Executive Officer bought 6,839 shares at $0.72 ($4,901)
  13. 4 Open-market buy Chief Executive Officer bought 6,783 shares at $0.74 ($4,995)
  14. 4 Open-market buy Chief Financial Officer bought 25,000 shares at $0.74 ($18,500)
  15. 4 Open-market buy Chief Executive Officer bought 20,000 shares at $0.74 ($14,796)
  16. 4 Open-market buy Chief Legal Officer, Corp. Sec bought 6,000 shares at $0.85 ($5,095)
  17. 4 Open-market buy Chief Executive Officer bought 13,000 shares at $1.85 ($24,064)
  18. 4 Open-market buy Chief Financial Officer bought 15,000 shares at $1.80 ($27,000)
  19. 4 Open-market buy Chief Medical Officer bought 10,000 shares at $1.95 ($19,500)
  20. 4 Derivatives Options or other derivatives

Page 3 of 5 · 88 filings